Ocular Therapeutix Inc OCUL:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/22/21 EDT
13.79quote price arrow down-0.14 (-1.00%)
Volume
450,376
52 week range
7.14 - 24.30

...

Loading . . .
  • Open13.90
  • Day High13.96
  • Day Low13.54
  • Prev Close13.79
  • 52 Week High24.30
  • 52 Week High Date12/16/20
  • 52 Week Low7.14
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap1.052B
  • Shares Out76.29M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-33.38

KEY STATS

  • Open13.90
  • Day High13.96
  • Day Low13.54
  • Prev Close13.79
  • 52 Week High24.30
  • 52 Week High Date12/16/20
  • 52 Week Low7.14
  • 52 Week Low Date09/04/20
  • Market Cap1.052B
  • Shares Out76.29M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change-33.38

RATIOS/PROFITABILITY

  • EPS (TTM)-2.28
  • P/E (TTM)-6.06
  • Fwd P/E (NTM)-19.70
  • EBITDA (MRQ)-63.776M
  • ROE (MRQ)-360.15%
  • Revenue (MRQ)22.14M
  • Gross Margin (MRQ)90.26%
  • Net Margin (MRQ)-591.81%
  • Debt To Equity (MRQ)57.57%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocular Therapeutix Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III...
Charles Warden
Non-Executive Chairman
Antony Mattessich
President
Donald Notman Jr.
Chief Financial Officer
Philip Strassburger J.D. Esq.
General Counsel
Address
24 Crosby Dr
Bedford, MA
01730-1402
United States

Top Peers

SYMBOLLASTCHG%CHG
ZGNX
Zogenix Inc
17.64-0.46-2.54%
OMER
Omeros Corp
15.46+0.14+0.91%
AERI
Aerie Pharmaceuticals Inc
17.71-0.09-0.51%
CDXC
Chromadex Corp
8.88-0.11-1.22%
RLMD
Relmada Therapeutics Inc
31.19+0.24+0.78%